Eko Health
Eko Health develops AI-powered digital tools to detect and monitor heart and lung disease
Actively Hiring
Overview
Eko is a digital health company advancing how healthcare professionals detect and monitor heart and lung disease with its suite of AI-powered digital tools. Its FDA-cleared technology is used by hundreds of thousands of healthcare professionals worldwide, allowing them to detect disease earlier and with higher accuracy, diagnose with more confidence, manage treatment effectively, and ultimately give their patients the best care possible. Eko is headquartered in Oakland, California, with over $125 million in funding from Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, and others.
Eko exists to ensure all patients have access to early heart and lung disease detection that improves and extends their lives.
Eko exists to ensure all patients have access to early heart and lung disease detection that improves and extends their lives.
Industries
Healthcare
Medical Devices
Artificial Intelligence
Mobile Health
Telemedicine